FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with ...
Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...
Intraocular lens (IOL) design has continued to evolve since being introduced in 1949. We have seen an evolution not only in design, but also in material, optics, safety, and efficacy, among other ...
Randomization (2:1:1) compared 78 mcg or 39 mcg BIM-IOL plus artificial tears versus standard monofocal IOL plus twice-daily ...
ASC management software company Mednet has launched a new tool for ophthalmology ASCs to run the full IOL tracking process, according to a Mednet news release. The new tool is available within the ...
Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...
What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” explains Dr. Levenson. These include: He points out that the choice to ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global ophthalmology devices market since 2015 and the market is poised to grow by USD 13.9 billion during 2019-2023, progressing at a CAGR ...
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...